---
title: Interventional Landing Page
---
[](https://www.haemonetics.com/)
- Businesses
- [Plasma](https://www.haemonetics.com/businesses/plasma)
- [Hospital](https://www.haemonetics.com/businesses/hospitals)
- [Blood Center](https://bloodcenter.haemonetics.com/)
- [Newsroom](https://www.haemonetics.com/newsroom)
- Careers
- [Careers Overview](https://www.haemonetics.com/careers)
- [Search and Apply](https://haemonetics.wd5.myworkdayjobs.com/HAE)
- [About Us](https://www.haemonetics.com/about-us)
- [Purpose, Mission and Values](https://www.haemonetics.com/about-us/purpose-mission-and-values)
- [Corporate Responsibility](https://www.haemonetics.com/about-us/corporate-responsibility)
- [Leadership](https://www.haemonetics.com/about-us/leadership)
- [Scientific Advisory Council](https://www.haemonetics.com/about-us/haemonetics-scientific-advisory-council)
- [Investor Relations](https://haemonetics.gcs-web.com/)
- [Investor Overview](https://haemonetics.gcs-web.com/)
- [Stock Information](https://haemonetics.gcs-web.com/stock-information/stock-quote)
- [Press Releases](https://haemonetics.gcs-web.com/press-releases)
- [Corporate Governance](https://haemonetics.gcs-web.com/corporate-governance)
- [SEC Filings](https://haemonetics.gcs-web.com/sec-filings)
- [Quarterly Earnings](https://haemonetics.gcs-web.com/quarterly-earnings)
- [Events & Presentations](https://haemonetics.gcs-web.com/events-presentations)
- [Investor Resources](https://haemonetics.gcs-web.com/investor-resources/information-request)
- [Support](https://www.haemonetics.com/support)
- - [Ordering and Sales](https://www.haemonetics.com/support/ordering-and-sales)
- [Accounts Receivable](https://www.haemonetics.com/support/ordering-and-sales/accounts-receivable)
- [Place an Order](https://www.haemonetics.com/support/ordering-and-sales/place-an-order)
- [Sales](https://www.haemonetics.com/support/ordering-and-sales/sales-inquiries)
- [Product Information](https://www.haemonetics.com/support/product-information)
- [Instructions for Use](https://www.haemonetics.com/support/product-information/instructions-for-use)
- [Product Certificates](https://www.haemonetics.com/support/certificates/product-certificates)
- [Safety Data Sheets](https://www.haemonetics.com/support/product-information/safety-data-sheets)
- [Download Center](https://dlc.haemonetics.com/#/login)
- [Warranty](https://www.haemonetics.com/-/media/files/terms-and-conditions/warranty-statement.pdf)
- [Training](https://www.haemonetics.com/support/training)
- [eLearning](https://www.haemonetics.com/support/training/e-learning)
- [Classes](https://www.haemonetics.com/support/training/classes)
- [Requests](https://www.haemonetics.com/support/training/requests)
- [Contact Us](https://www.haemonetics.com/contact-support)
Go
Technical Support
Order Tracking
# Close with Confidence
The interventional market is large and diverse, with multiple specialties and procedures being offered. Haemonetics is pleased to be your closure of choice, offering a family of products to meet your closure needs. Our VASCADE® closure system covers both your femoral artery and veins 5-7F access. Our VASCADE MVP® closure system closes 6-12 F ID (up to 15F OD) venous access.
[Request Information](https://hospital.haemonetics.com/request-information?franchise_information=Vascular%20Closure&vascular_closure_products=VASCADE)
SPONSORED PODCAST
# Vascular Access, Closure, and Devices: Best Practices and the Future
Featuring Pradeep Nair, MD
[](https://cta-redirect.hubspot.com/cta/redirect/4551484/5f169293-57ae-4002-94ae-c2aaa1b11843)
**Webinars & Videos**
Hear from the experts themselves and discover how the VASCADE system has reshaped their approach to real-world challenges. Dive deep into real cases and explore the solutions that have worked best, gaining valuable insights from thought leaders and peers who have experienced the benefits firsthand.
[](https://info.haemonetics.com/closurevideos)
**Why Choose VASCADE?**
VASCADE is the next-generation femoral arterial and venous closure system from Haemonetics. The system combines our proven collapsible disc technology and a thrombogenic resorbable extravascular collagen to enable rapid hemostasis while minimizing complications.
[](https://cta-redirect.hubspot.com/cta/redirect/4551484/552e595d-9c87-43da-9d7d-1a1ddde3e329)
**Clinical Data**
[RESPECT Publication](https://hospital.haemonetics.com/-/media/files/hospital/transfusion-management/attachment-2-hermiller.pdf)
The RESPECT trial was aimed at evaluating safety/efficacy of a new extravascular closure system in diagnostic (Dx) and interventional (Ix) procedures performed through 6 or 7 Fr introducer sheaths.
[ANTEGRADE-PVD Publication](https://hospital.haemonetics.com/-/media/files/hospital/transfusion-management/attachment-3-walker.pdf)
This study evaluated short-term outcomes when sealing antegrade femoral puncture sites with an extravascular site-closure system after peripheral endovascular procedures.
[Yale University Study of Vascular Closure in Severe Femoral Artery Disease](https://info.haemonetics.com/hubfs/EX%205827%20Nagpal%202022%20Real-world%20VASCADE%20closure%20device%20versus%20manual%20compression%20use%20and%20outcomes%20in%20patients%20(1).pdf)
This single-center, retrospective study evaluated the safety and efficacy of VASCADE compared to MC in patients undergoing PVI (Peripheral Vascular Intervention) with at least moderate access site disease.
**Brochures**
- [VASCADE Brochure](https://hospital.haemonetics.com/-/media/files/hospital/vascular-closure/lit_5399_rev_c_-_vascade_product_brochure_1-(1).pdf)
- [VASCADE MVP Brochure](https://hospital.haemonetics.com/-/media/files/hospital/vascular-closure/lit_4344_rev_d_-_vascade_mvp_product_brochure-(2).pdf)
**Instructions for Use**
- [VASCADE Instructions for Use](https://hospital.haemonetics.com/-/media/files/hospital/vascular-closure/ifu_2611-t-_vascade_instructions_for_use.pdf?sc_lang=en)
- [VASCADE MVP Instructions for Use](https://hospital.haemonetics.com/-/media/files/hospital/vascular-closure/ifu_3972-k-_vascade_mvp_vvcs.pdf)
## Performance Guarantee
We offer a unique outcomes-based and risk-sharing purchasing program called the VASCADE® Performance Guarantee.
**Sharing Risk by Sharing Cost.**
[Learn more](https://hospital.haemonetics.com/vascular-closure/vascade-performance-guarantee)
.png "Video Screenshot (2)")
\*Workflow improvements by improvement of Time to hemostasis, Time to ambulation, and time to discharge eligibility
Natale A, et al. Venous vascular closure system versus manual compression following multiple access electrophysiology procedures: The AMBULATE Trial. JACC Clin Electrophysiol 2020; 6(1):111-124.
Hermiller JB, et al. A Prospective, Randomized, Pivotal Trial of a Novel Extravascular Collagen-Based Closure Device Compared to Manual Compression in Diagnostic and Interventional Patients Journal of Invasive Cardiology 2015;27(3):129-136
We make it possible. You make it matter.
- [Privacy Statement](https://www.haemonetics.com/privacy-statement)
- [Terms & Conditions](https://www.haemonetics.com/terms-and-conditions)
- [Careers](https://www.haemonetics.com/careers)
- [Trademarks](https://www.haemonetics.com/about-us/trademarks)
- Update Cookie Terms
-
-
-
© 2022 Haemonetics Corporation